中食民安(08283.HK)擬折讓約17.81%配售最多960萬股 淨籌約540萬港元
格隆匯7月14日丨中食民安(08283.HK)公告,於2025年7月14日,公司與配售代理訂立了配售協議。根據協議,公司有條件同意透過配售代理按竭誠基準配售最多960萬股配售股份予不少於六名承配人。承配人及其最終實益擁有人(如適用)須爲獨立第三方。配售價爲每股配售股份0.60港元。
配售價每股配售股份0.60港元較於配售協議日期聯交所所報每股股份收市價0.73港元折讓約17.81%;配售事項所得款項淨額上限約540萬港元擬(i)約240萬港元用作開展營銷活動,推廣集團即食食品業務;及(ii)約300萬港元用作未來對即食食品行業內上遊供應鏈的投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.